Clinical trial · Interventional
Evaluation of Different Colorectal Cancer Screening Strategies
Evaluation of Different Colorectal Cancer Screening Strategies: a Prospective Randomized Trial
NCT05440565CI-TRIAL-00059431unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A large-scale randomized controlled trial was conducted to compare different colorectal neoplasms screening strategies.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Neoplasms | Colorectal Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| APCS score | Diagnostic Test | — | UNRESOLVED |
| Fecal immunochemical test | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- Risk score
- interventionNames
- Diagnostic Test: APCS score
- type
- ACTIVE_COMPARATOR
- label
- Fecal immunochemical test
- interventionNames
- Diagnostic Test: Fecal immunochemical test
Primary outcomes (1)
- measure
- Detection rate
- timeFrame
- up to 30 months
- description
- Detection of intestinal lesions in population
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 74 Years
Show eligibility criteria text
Inclusion Criteria: * 50-74 years old * Informed consent is available Exclusion Criteria: * Previous colorectal cancer * Previous colorectal resection * Previous received cancer-related treatment (except non-melanoma skin cancer) * Colonoscopy, sigmoidoscopy, CT colonoscopy, and barium enema were performed within 5 years * Fecal occult blood or fecal DNA was performed within one year * Symptoms of lower digestive tract diseases requiring colonoscopy include: (1) rectal bleeding occurred more than once in the past 6 months, (2) recorded iron deficiency anemia, and (3) recorded significant weight loss within 6 months (\> 10% of baseline weight) * Suffering from other diseases that affect the benefit of screening or intolerance to colonoscopy (for example, severe pulmonary disease, end-stage renal disease, end-stage liver disease, severe heart failure or recently diagnosed cancer, except non-melanoma skin cancer)
References
Publications (0)
Data not yet available
No reference posted for this study.